Department of General Surgery, Dicle University Faculty of Medicine, Diyarbakir/Turkey.
Medicine (Baltimore). 2022 Aug 5;101(31):e29582. doi: 10.1097/MD.0000000000029582.
The aim of our study was to investigate the prognostic role of platelet/albumin ratio in patients treated under emergency conditions for peptic ulcer perforation (PUP).
A retrospective study involving emergency patients who were operated for PUP was carried out. The patients were divided into 2 groups: PUP patients who died after surgical treatment (PUP-M) and PUP patients who survived after surgical treatment (PUP-S). The laboratory values of the patients were compared statistically. A P value of <.05 was considered statistically significant.
This cohort study consisted of 171 patients treated between June 2013 and December 2019. The mean age of the patients was 46.3 ± 20.5 years; and 33 (19.3%) patients were women. The age (P ≤ .001), platelet/lymphocyte ratio (P = .02), lactic dehydrogenase to albumin ratio (P ≤ .001), and platelet/albumin ratio (PAR; P ≤ .001) values were high and lymphocyte count was low (P = .006) in the PUP-M group. A positive correlation was determined between length of stay in hospital and age (P ≤ .001), lactic dehydrogenase/albumin ratio (P ≤ .001), platelet count (P = .044), and PAR (P ≤ .001). A substantial negative correlation was determined between length of stay in hospital and albumin count (P ≤ .001).
We determined a high preoperative PAR level in PUP patients who had undergone surgery as a negative prognostic parameter. PAR is a candidate biomarker for clinical practice.
本研究旨在探讨血小板/白蛋白比值(PAR)对接受紧急治疗的消化性溃疡穿孔(PUP)患者的预后价值。
本回顾性研究纳入了因 PUP 而行手术治疗的急诊患者。根据术后转归,将患者分为 PUP 术后死亡(PUP-M)组和 PUP 术后存活(PUP-S)组。比较两组患者的实验室检查值。P 值<.05 认为具有统计学意义。
本队列研究共纳入了 2013 年 6 月至 2019 年 12 月期间接受治疗的 171 例患者。患者的平均年龄为 46.3±20.5 岁,女性 33 例(19.3%)。PUP-M 组患者的年龄(P≤.001)、血小板/淋巴细胞比值(P=.02)、乳酸脱氢酶/白蛋白比值(P≤.001)和 PAR(P≤.001)均较高,淋巴细胞计数(P=.006)较低。住院时间与年龄(P≤.001)、乳酸脱氢酶/白蛋白比值(P≤.001)、血小板计数(P=.044)和 PAR(P≤.001)呈正相关,与白蛋白计数(P≤.001)呈负相关。
我们发现手术治疗的 PUP 患者术前 PAR 水平较高,这是一个预后不良的指标。PAR 可能是一种有临床应用价值的生物标志物。